Adipokines and the Risk of Reflux Esophagitis

• Conditions: Reflux Esophagitis; Visceral Obesity

• Registration Number: NCT01560598
• Lead Sponsor: Seoul National University Hospital

Brief Summary

We aimed to risk faoctors for GERD and association between visceral obesity, plasma adipoline(leptin, adiponectin, IL-6, TNF-α)and development of reflux esophagitis in healthy Koreans.

Detailed Description

Not available

Basic Information
|
Recruitment & Eligibility
|
Study & Design
|
Trial Locations

Study Timeline

• Status Verified: 2012-03
• Study First Submitted: 2012-03-20
• Study First Submitted QC: 2012-03-21
• Last Update Submitted: 2012-03-21
• Study First Posted: 2012-03-22
• Last Update Posted: 2012-03-22
• Study Start: 2012-06
• Primary Completion: 2013-06

Recruitment & Eligibility

• Status: UNKNOWN
• Sex: All
• Target Recruitment: 600

Inclusion Criteria

• endoscopically proven reflux esophagitis

Read More

Exclusion Criteria

• those with esophageal hiatal hernia, current PPI medication, upper GI operation history

Read More

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Difference in serum adipokine levels between case and control groups	2 month lager (after sampling)

Trial Locations

Locations (1)

Seoul National University Hospital Healthcare System Gangnam Center; 🇰🇷 Seoul, Korea, Republic of